$10.33
38.03% yesterday
Nasdaq, Aug 01, 10:00 pm CET
ISIN
US81728A1088
Symbol
SNSE

Sensei Biotherapeutics Inc Stock price

$10.33
+1.48 16.67% 1M
+0.77 8.07% 6M
+0.52 5.34% YTD
-2.78 21.21% 1Y
-28.08 73.11% 3Y
-369.68 97.28% 5Y
-369.68 97.28% 10Y
-369.68 97.28% 20Y
Nasdaq, Closing price Fri, Aug 01 2025
+2.85 38.03%
ISIN
US81728A1088
Symbol
SNSE
Industry

Key metrics

Basic
Market capitalization
$13.0m
Enterprise Value
$-20.7m
Net debt
positive
Cash
$34.3m
Shares outstanding
1.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.9
P/B
0.4
Financial Health
Equity Ratio
84.6%
Return on Equity
-78.6%
ROCE
-94.3%
ROIC
-887.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-30.1m | $-28.3m
EBIT
$-31.2m | $-28.0m
Net Income
$-29.0m | $-27.3m
Free Cash Flow
$-24.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
10.0% | 6.9%
EBIT
10.4% | 11.5%
Net Income
9.1% | 9.4%
Free Cash Flow
13.3%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-23.0
FCF per Share
$-19.3
Short interest
0.9%
Employees
28
Rev per Employee
$0.0
Show more

Is Sensei Biotherapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,028 stocks worldwide.

Sensei Biotherapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Sensei Biotherapeutics Inc forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Sensei Biotherapeutics Inc forecast:

Buy
89%
Hold
11%

Financial data from Sensei Biotherapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 13 13
24% 24%
-
- Research and Development Expense 17 17
3% 3%
-
-30 -30
10% 10%
-
- Depreciation and Amortization 1.03 1.03
22% 22%
-
EBIT (Operating Income) EBIT -31 -31
10% 10%
-
Net Profit -29 -29
9% 9%
-

In millions USD.

Don't miss a Thing! We will send you all news about Sensei Biotherapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sensei Biotherapeutics Inc Stock News

Neutral
GlobeNewsWire
3 days ago
BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that clinical data from the dose expansion cohort of the Phase 1/2 trial of solnerstotug alone and in combination with Libtayo® (cemiplimab), Regeneron's PD-1 ...
Neutral
GlobeNewsWire
about 2 months ago
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will implement a 1-for-20 reverse stock split of its issued and outstanding shares of common stock ("Reverse Stock Split"), effective at 5:00 p.m. Easter...
Neutral
GlobeNewsWire
3 months ago
- Favorable clinical data in PD-(L)1 resistant patients - - Dose expansion enrollment complete with full data expected by year-end 2025 - - Cash runway into the second quarter of 2026 - BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer pa...
More Sensei Biotherapeutics Inc News

Company Profile

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation of immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Head office United States
CEO John Celebi
Employees 28
Founded 1999
Website www.senseibio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today